DGX
DGX
NYSE · Health Care

Quest Diagnostics Inc

$187.39
-3.45 (-1.81%)
As of May 9, 1:05 AM ET ·
DGX News10 articles
IonQ Lifts 2026 Revenue Forecast as Quantum Sales Surge, but Profit Questions Linger
IonQ raised its 2026 revenue forecast after a strong Q1, but shares fell 6% after hours as investors weigh persistent losses and the path to quantum profitability.
Earnings
Citi's $52 Million Hire Faces New Questions Ahead of Investor Day
Citigroup's high-profile $52 million hire of Vis Raghavan is under new scrutiny after reports he was ousted from JPMorgan amid years of complaints, just ahead of Citi's May 7 investor day.
Markets
FTC Second Request Pauses IonQ's $1.8B SkyWater Acquisition
IonQ's $1.8B acquisition of SkyWater Technology hit an FTC second request, pausing the merger timeline. Shares closed at $42.69, down 2.19%.
Regulation
GameStop Shares Dip as Trade-In Promotion Ends, Valuation Questions Loom
GameStop shares slipped 1.6% to $25.24 after a promotional trade-in deal ended, reigniting debate over the company's valuation and its transition to collectibles.
Markets
United CEO Evades American Merger Questions Amid Political Headwinds, Fuel Pressures
United Airlines CEO Scott Kirby declined to address potential merger interest with American Airlines, maintaining speculation after President Trump voiced opposition. United trimmed its 2026 forecast as rising jet-fuel costs pressure margins.
Markets
Archer Aviation Valuation Questioned Amid Steep Decline; Singapore Mid-Caps Shine
Archer Aviation faces valuation scrutiny after shares drop 39% over three months. Meanwhile, Singapore's mid-cap stocks led by Frencken Group outperformed blue chips in Q1 2026.
Markets
Blue Owl Limits Redemptions at Key Credit Funds Amid Surge in Withdrawal Requests
Blue Owl Capital has imposed a 5% quarterly redemption cap on two major private credit funds following a surge in withdrawal requests, with one fund facing over 40% in redemption demands.
Markets
Alphabet Shares Slide as Investors Question Massive AI Spending Plan
Alphabet shares declined over 3% Thursday, extending a 15% retreat from February peaks, as investors expressed concern over the company's ambitious plan to increase capital spending to $185 billion by 2026.
Technology
Palantir Faces Pentagon AI Ban Fallout as Defense Tech Reliance Questioned
Palantir Technologies confronts new risks as the U.S. Pentagon designates AI supplier Anthropic a supply-chain threat, raising concerns over its defense software dependencies. Broader market jitters add to the pressure.
Regulation
Vale Shares Dip Premarket as Brazilian Courts Deny Major Asset Freeze Requests
Vale's U.S.-listed shares declined 0.8% in premarket trading after Brazilian courts rejected asset freeze requests totaling 2.846 billion reais, with investors awaiting quarterly results.
Markets